Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials

IntroductionPsychedelic agents have regained the attention of pharmaceutical companies as promising treatments for depressive episodes. 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), an atypical psychedelic, is emerging as a potentially effective, novel rapid-acting antidepressant. In this systematic...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Aleksander Kwaśny, Alina Wilkowska, Wiesław Jerzy Cubała
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2024-09-01
Saila:	Frontiers in Psychiatry
Gaiak:	5-methoxy-N,N-dimethyltryptamine 5-MeO-DMT safety tolerability adverse events side effects
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1477996/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!